Cite
HARVARD Citation
Tokatlian, T. et al. (2022). Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells. Journal for immunotherapy of cancer. 10 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tokatlian, T. et al. (2022). Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells. Journal for immunotherapy of cancer. 10 (1), p. . [Online].